News of electric car giant Tesla’s progress toward rolling out its advanced driver-assistance feature in China isn’t as groundbreaking as investors are treating it, according to a top tech investor.
Mark Hawtin, GAM Investment Management’s investment director focused on investing in disruptive growth and technology stocks, told CNBC’ “Squawk Box Europe” Thursday that such expectations were misleading — not least because Tesla’s Full Self Driving service doesn’t offer full autonomous driving.
“We should say what they’re doing — everyone’s talking about this full self-driving capability,” Hawtin told CNBC. “What they’re going to be able to do in China is what they already do in the U.S. or U.K., which is sort of this assisted-driver capability.”
On Monday, shares of Tesla rose sharply, notching their best day since March 2021, after it passed a significant milestone toward the launch of FSD in China. Local Chinese authorities removed restrictions on its cars after passing the country’s data security requirements, Tesla said Sunday.
This raised expectations that Tesla’s FSD would soon be available in China. Tesla shares are up 6.7% in the last five trading days, largely on the back of buzz surrounding its roadmap to bringing FSD to China — plus, comments from CEO Elon Musk about plans to start production of more affordable models in early 2025.
But Hawtin said that the company’s so-called Full Self Driving service lacks the qualities that would make it an example of truly self-driving technology.
“It’s by no means autonomous driving yet,” he told CNBC. He thinks that a version of Tesla FSD capable of “true autonomy” is still five to 10 years away.
Hawtin said that Tesla’s reported deal with China’s Baidu is a bigger short-term win for Baidu than Tesla, adding that competition is intense in China with names like BYD, Huawei, Xpeng, Li Auto, and Xiaomi all supplying technology capable of Level 2 autonomy.
Tesla reportedly scored a deal with Baidu that would allow Musk’s firm to tap into Baidu’s mapping service license, a key requirement for offering FSD on Chinese public roads, per Reuters.
Tesla was not immediately available for comment when contacted by CNBC.
Full Self Driving, or FSD, is an upgrade to Tesla’s Autopilot driver assistant. Tesla doesn’t yet make or sell cars capable of full autonomous driving. It sells “Level 2” driver-assistance systems, marketed under the brand name FSD.
“Level 3” assisted driving, otherwise known as “conditional automation,” entails systems that handle all aspects of driving, but a driver still must be present, according to the SAE standards-setting organization.
Tesla has offered its FSD technology in China for years, but with a restricted feature set that limits it to operations like automated lane changing.
GAM does not own shares of Tesla, and Hawtin said he doesn’t personally own shares either.
– CNBC’s Lora Kolodny and Evelyn Cheng contributed to this report
stromectol over the counter – ivermectin 3mg tablets order tegretol 400mg sale
buy cheap generic amoxil – order combivent without prescription buy generic ipratropium over the counter
where to buy azithromycin without a prescription – tindamax pill purchase bystolic online
how to buy neurontin – anafranil price itraconazole uk
lasix medication – cost betnovate 20 gm3 oral betnovate
monodox cost – buy albuterol pills glipizide buy online
buy generic augmentin for sale – order augmentin 1000mg pill buy duloxetine 40mg pill
amoxiclav sale – buy cheap generic augmentin duloxetine 20mg cost
rybelsus 14 mg price – cyproheptadine 4mg canada oral periactin
viagra online order – oral tadalafil 5mg cialis 40mg cheap
brand cenforce 50mg – glycomet 1000mg over the counter glycomet 1000mg uk
buy omeprazole no prescription – atenolol online order purchase tenormin pill
methylprednisolone 16mg pills – buy methylprednisolone pills brand triamcinolone
misoprostol 200mcg uk – how to get diltiazem without a prescription diltiazem 180mg over the counter
order acyclovir 400mg – buy crestor generic buy crestor online cheap
purchase motilium generic – buy motilium 10mg sale cost cyclobenzaprine